Latest "Allergy Therapeutics" News Stories

21:49 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Allergy Therapeutics" found in our extensive news archives from over 250 global news sources.

More Information about Allergy Therapeutics on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Allergy Therapeutics for you to read. Along with our medical data and news we also list Allergy Therapeutics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Allergy Therapeutics Companies for you to search.

Showing "Allergy Therapeutics" News Articles 1–25 of 8,400+


Allergy Therapeutics' latest data highlights benefits of adjuvant technology

Commercial biotechnology firm Allergy Therapeutics on Monday published new data highlighting its technology's effectiveness as an adjuvant compared to existing treatments. According to Allergy Ther...

DGAP-News: Allergy Therapeutics plc berichtet vorläufige Ergebnisse für das zum 30. Juni 2018 endende Geschäftsjahr (deutsch)

Allergy Therapeutics plc berichtet vorläufige Ergebnisse für das zum 30. Juni 2018 endende Geschäftsjahr DGAP-News: Allergy Therapeutics plc / Schlagwort(e): Jahresergebnis Allergy Therapeutics pl...

Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results

Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and plans to launch a Phase III study next year. British biotech Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine. ... The post Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results appeared first on

Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers

Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple providers of allergen immunotherapy products including sub-cutaneous, sublingual, and oral allergy medicines designed to treat patients of allergy and asthma.  Allergen immunothe...

Allergy Therapeutics readies grass pollen treatment for phase III trial after “extremely positive” mid-stage results

The phase II study of Allergy Therapeutics’ PQ Grass immunotherapy – an aluminium-free, ultra-short course hay fever treatment – evaluated dose response and safety

Allergy Therapeutics highlights benefits of adjuvant technology in new paper

The study highlighted Allergy’s microcrystalline tyrosine (MCT) was a suitable and flexible alternative to aluminium hydroxide

Intrommune Therapeutics Submits Pre-IND Meeting Request to the U.S. FDA for INT301, Its Peanut Allergy Oral Mucosal Immunotherapy Drug Candidate, During Food Allergy Awareness Week

New York, May 15, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a NYC-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food allergies, submitted its request for a Pre-IND meeting with the FDA to review its first product candidate, INT301. INT301 is an oral mucosal immunotherapy (OMIT) product for the long-term treatment of pe...

Allergy Therapeutics records 'highly positive' results from recent dosing study

Commercial biotechnology company Allergy Therapeutics has seen "highly positive" top-line results from a recent phase two dose-ranging study on its grass-pollen induced seasonal allergic rhinitis d...

Positive House Dust Mite Immunotherapy Results for UK Biotech

British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s been a good month for Allergy Therapeutics, which also reported positive Phase II results for its grass pollen allergy vaccine trial last week. It seems ... The post Positive House Dust Mite Immunotherapy Results for UK Biotech appeared first on

Allergy Therapeutics on track for phase III grass pollen trial in 2019

Manuel Llobet, chief executive of Allergy Therapeutics plc (LON:AGY), spoke to Proactive Investors after reporting  “extremely positive results” from the phase II trial of their grass pollen-induced hay fever immunotherapy. Llobet says PQ Grass met its primary endpoint, with those taking the drug showing “a highly statistically significant” reduction in symptoms compared to patien...

Japanese cedar allergy drug reimbursed in Japan

Allergy specialist ALK has announced that reimbursement has been agreed for its sublingual allergy immunotherapy…

Medical News Today: Can you have a garlic allergy?

A garlic allergy is rare, but it is possible. In this article, we look at the symptoms of a true allergy, which include sneezing, dizziness, and in severe cases, anaphylaxis. We also describe the milder symptoms of a garlic intolerance. Learn when to see a doctor for allergy testing.

Allergy Therapeutics full-year revenues to rise once again despite “unusually weak” pollen season

The allergy vaccines maker expects to report a 6.6% rise in revenues for the year ended June 30

Food allergy: Death is not our only fear

Recently, a respected allergist reassured his audience: the mortality rate for food allergy is very low. The risk of dying in a car crash is much greater than the risk of dying from food allergy. The implication seemed to be that the anxiety around food allergy is misplaced. Though any loss of life is too […]

Ocular Allergy as a Risk Factor for Dry Eye

Ocular allergy and dry eye are different conditions, yet there are complex interactions between them. Find out what there is to know. Current Opinion in Allergy and Clinical Immunology

Health Tip: Create a Food Allergy Plan

-- If you've been diagnosed with a food allergy, it is important to develop a food allergy plan so you and others know what to do in an emergency. Milder symptoms of food allergy include itching, sneezing, hives or rashes. More severe symptoms, such...

Allergy clinic finds large percentage of anaphylaxis cases from tick bite meat allergy

(American College of Allergy, Asthma, and Immunology) An increase in the Lone Star tick population since 2006, and the ability to recognize the ticks as the source of 'alpha gal' allergy to red meat has meant significantly more cases of anaphylaxis being properly identified.

Allergy Therapeutics raises £10.6mln to fund expansion of late-stage PQ Grass study

As well as funding the late-stage PQ Grass trial, the cash will also be used to part-fund the phase II study of Acarovac, the company’s dust mite allergy treatment

Health Tip: Understanding Allergy Blood Testing

-- Allergy testing may be recommended for people who suspect they react to allergens such as animal dander, food, dust or pollen. When you have an allergy, your immune system treats this type of harmless substance as a threat. To fight this...

Peanut Allergy: Epidemiology Forecast to 2027 [Report Updated: 21052018] Prices from USD $3995

Peanut Allergy: Epidemiology Forecast to 2027SummaryPeanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E IgE mediated typeI hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The m...

Nasal mist vaccine suppresses peanut allergy in mice

(Food Allergy Research & Education) A new research study publishedin the Journal of Allergy and Clinical Immunology and supported by FARE reports that a vaccine delivered as an ultrafine nasal spray was found to limit or prevent peanut allergy symptoms in mice. This study, conducted by researchers with the Mary H. Weiser Food Allergy Center at the University of Michigan, is the first step in poten...

Medical News Today: What to know about a watermelon allergy

A watermelon allergy is rare, and symptoms include coughing, hives, and stomach cramping. A person can treat a mild allergic reaction with over-the-counter medication, but serious reactions may require emergency treatment. Learn more about an allergy to watermelon and how to handle it here.

Intrommune Therapeutics Completes Pre-IND Meeting With FDA on INT301 for Peanut Allergy

New York, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food allergies, today announced that it recently participated in a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory p...

Allergy Therapeutics reports Phase II data for grass pollen therapy

Allergy Therapeutics plc - Positive new data with house-dust mite immunotherapy

Allergy Therapeutics plc("Allergy Therapeutics", the “Group” or “Company") Positive new clinical data with house-dust mite immunotherapy ~ House-dust mite immunotherapy shown to be well-tolerated and demonstrates highly significant symptom improvement ~ ~ Allergy experts present an overview of adjuvants at satellite symposium during EAACI 2018 ~ 29 May 2018 Allergy Therapeutics plc ...

Quick Search


News Quicklinks